-
UroGen Pharma's (URGN) "Buy" Rating Reaffirmed at D. Boral Capital
Source: Buzz FX / 23 Jan 2025 08:16:18 America/New_York
UroGen Pharma's (URGN) "Buy" Rating Reaffirmed at D. Boral Capital Written by MarketBeat January 23, 2025 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating reiterated by analysts a
Read more...